ActiveSight

ActiveSight is a structural biology contract research organization (CRO) that provides protein crystallography services to the pharmaceutical and biotechnology industries. The company specializes in protein expression, purification, and X-ray crystallography to facilitate structure-based drug design. Their core service involves the production of "Ready-to-Diffract" protein crystals and the determination of protein-ligand complex structures. By providing high-resolution structural data, ActiveSight assists researchers in the lead optimization phase of drug discovery. In 2011, ActiveSight was acquired by Rigaku Americas Corporation, a leader in X-ray analytical instrumentation. The acquisition allowed Rigaku to expand its portfolio from selling hardware to providing comprehensive structural biology services.